Literature DB >> 26869556

Australia commits funds to curb hepatitis C epidemic.

Chris McCall.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26869556     DOI: 10.1016/S0140-6736(16)00212-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Iatrogenic Cushing Syndrome from Interaction Between Ritonavir and Oral Budesonide During Direct Acting Antiviral Hepatitis C Therapy.

Authors:  Sern Wei Yeoh
Journal:  J Clin Exp Hepatol       Date:  2016-05-20

2.  Projections of primary liver cancer to 2030 in 30 countries worldwide.

Authors:  Patricia C Valery; Mathieu Laversanne; Paul J Clark; Jessica L Petrick; Katherine A McGlynn; Freddie Bray
Journal:  Hepatology       Date:  2017-12-23       Impact factor: 17.425

Review 3.  Hepatitis C Virus Epidemiology and the Impact of Interferon-Free Hepatitis C Virus Therapy.

Authors:  Jeffrey V Lazarus; Elena Roel; Ahmed M Elsharkawy
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.